Literature DB >> 2026897

Fluconazole resistant candida in AIDS.

R Fox, K R Neal, C L Leen, M E Ellis, B K Mandal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2026897     DOI： 10.1016/0163-4453(91)91767-r

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  37 in total

Review 1.  Antifungal prophylaxis during neutropenia and immunodeficiency.

Authors:  O Lortholary; B Dupont
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

Review 2.  Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.

Authors:  M A Ghannoum; J H Rex; J N Galgiani
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 3.  Resistance of Candida species to fluconazole.

Authors:  J H Rex; M G Rinaldi; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

4.  Candida and bacterial mandibular osteomyelitis in an AIDS patient.

Authors:  C Sanz-Rodriguez; F Hernandez-Surmann; A G Bueno; C Goizueta; A Noguerado
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-07       Impact factor: 3.267

5.  Prior fluconazole exposure as an independent risk factor for fluconazole resistant candidosis in HIV positive patients: a case-control study.

Authors:  J D Cartledge; J Midgley; B G Gazzard
Journal:  Genitourin Med       Date:  1997-12

6.  Nosocomial Candida glabrata colonization: an epidemiologic study.

Authors:  J A Vazquez; L M Dembry; V Sanchez; M A Vazquez; J D Sobel; C Dmuchowski; M J Zervos
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

7.  In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.

Authors:  F Barchiesi; A L Colombo; D A McGough; A W Fothergill; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

8.  Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients.

Authors:  N Troillet; C Durussel; J Bille; M P Glauser; J P Chave
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-12       Impact factor: 3.267

9.  Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients.

Authors:  D Sullivan; D Bennett; M Henman; P Harwood; S Flint; F Mulcahy; D Shanley; D Coleman
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

10.  Fluconazole resistance in Candida glabrata.

Authors:  C A Hitchcock; G W Pye; P F Troke; E M Johnson; D W Warnock
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.